Using current techniques, Alzheimer’s disease, the most frequent cause of dementia, can only be detected once the typical plaques have formed in the brain. At this point, therapy seems no longer possible. However, the first changes caused by Alzheimer’s take place on the protein level up to 20 years sooner. A two-tier method developed at Ruhr-Universität Bochum (RUB) can help detect the disease at a much earlier stage. The researchers from Bochum published their report in the March 2019 edition of the journal “Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring”.
“This has paved the way for early-stage therapy approaches, where the as yet inefficient drugs on which we had pinned our hopes may prove effective,” says Professor Klaus Gerwert from the Department of Biophysics at RUB.
Protein folds incorrectly
In Alzheimer’s patients, the amyloid beta protein folds incorrectly due to pathological changes long before the first symptoms occur. A team of researchers headed by Klaus Gerwert successfully diagnosed this misfolding using a simple blood test; as a result, the disease can be detected approximately eight years before the first clinical symptoms occur. The test wasn’t suitable for clinical applications however: it did detect 71 per cent of Alzheimer’s cases in symptomless stages, but at the same time provided false positive diagnoses for nine per cent of the study participants. In order to increase the number of correctly identified Alzheimer’s cases and to reduce the number of false positive diagnoses, the researchers poured a lot of time and effort into optimising the test.
As a result, they have now introduced the two-tier diagnostic method. To this end, they use the original blood test to identify high-risk individuals. Subsequently, they add a dementia-specific biomarker, namely tau protein, to run further tests with those test participants whose Alzheimer’s diagnosis was positive in the first step. If both biomarkers show a positive result, there is a high likelihood of Alzheimer’s disease. “Through the combination of both analyses, 87 of 100 Alzheimer’s patients were correctly identified in our study,” summarises Klaus Gerwert. “And we reduced the number of false positive diagnoses in healthy subjects to 3 of 100. The second analysis is carried out in cerebrospinal fluid that is extracted from the spinal cord.
“Now, new clinical studies with test participants in very early stages of the disease can be launched,” points out Gerwert. He is hoping that the existing therapeutic antibodies will still have an effect. “Recently, two major promising studies have failed, especially Crenezumab and Aducanumab – not least because it had probably already been too late by the time therapy was taken up. The new test opens up a new therapy window.”
“Once amyloid plaques have formed, it seems that the disease can no longer be treated,” says Dr. Andreas Nabers, head of the research group and co-developer of the Alzheimer’s sensor. “If our attempts to arrest the progression of Alzheimer’s fail, it will put a lot of strain on our society.”
Sensor test is simple and robust
The blood test has been upgraded to a fully automated process at the RUB Department of Biophysics. “The sensor is easy to use, robust when it comes to fluctuation in concentration of biomarkers, and standardised,” explains Andreas Nabers. “We are now conducting in-depth research to detect the second biomarker, namely tau protein, in the blood, in order to supply a solely blood-based test in future,” concludes Klaus Gerwert.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- After 40 years, the Alzheimer’s Association sees signs of progress against a devastating disease. Is it real?on February 24, 2020 at 6:24 am
CHICAGO — In 1979, a man named Jerome Stone, frustrated with the lack of options and information about Alzheimer’s disease following his wife’s diagnosis, brought together experts and families ...
- B. Smith, Restaurateur And Lifestyle Icon, Dies At 70 Of Early Onset Alzheimer'son February 24, 2020 at 1:46 am
The world is less generous and less welcoming because B. Smith, former model, entertainer and lifestyle doyenne, has left it. At age 70, Smith succumbed to early onset Alzheimer's, which she had been ...
- Alzheimer's Drugs Market by 2024 Worldwide Growth Opportunities Recent Trends Forecast by Types and Application to 2024on February 24, 2020 at 1:37 am
Alzheimer's Drugs Market 2020 reports contains Industry Analysis, Market Share, Size with Sales, Price, Revenue, Gross Margin, Competitor analysis and Forecast to 2024. Alzheimer's Drugs Market top ...
- Subzero Heroes event raises $106,000 for Alzheimer's Associationon February 23, 2020 at 5:14 pm
The annual jump started in 2000 with 25 jumpers and about 40 onlookers, this year the event raised more than $106,000 for the Alzheimer's Association Hudson Valley Chapter, announced the organization ...
- B. Smith, Lifestyle Guru, Restaurateur And Former Model, Dies From Alzheimer’s Diseaseon February 23, 2020 at 4:27 pm
B. Smith, the groundbreaking lifestyle guru, restaurateur, author and former model, died on Saturday (Feb. 22) from early on-set Alzheimer’s disease. She was 70. Smith’s husband, Dan Gasby, announced ...
- B. Smith, Lifestyle Guru, Restauranteur And Former Model, Dies From Alzheimer’s Diseaseon February 23, 2020 at 3:57 pm
Viola Davis, Ava DuVernay and more honor the legendary entrepreneur. B. Smith, the groundbreaking lifestyle guru, restauranteur, author and former model, died on Saturday (Feb. 22) from early on-set ...
- TV host and lifestyle expert B. Smith dies of Alzheimer’son February 23, 2020 at 1:08 pm
Television personality, fashion model and entrepreneur B. Smith has died at age 70 after a seven-year battle with Alzheimer’s. Smith’s death was confirmed by her husband Dan Gasby, stating she died ...
- Model, restaurateur B. Smith dies at 70 during battle with early onset Alzheimer'son February 23, 2020 at 12:38 pm
B. Smith, the model turned lifestyle guru and restaurateur, has died at 70 years old during her battle with early onset Alzheimer's, her husband, Dan Gasby, announced on Sunday. Barbara Elaine Smith ...
- B. Smith's husband criticized for having girlfriend while she battles Alzheimer'son February 23, 2020 at 12:08 pm
Dan Gasby has fired back at critics upset that he has a girlfriend while caring for his ailing wife of 26 years.
- B. Smith, model-turned-TV host and lifestyle guru, dies at 70 after Alzheimer's battleon February 23, 2020 at 9:47 am
B. Smith, one of the country's first high-profile black models who went on to become an author, restaurateur and lifestyle maven, has died after a seven-year battle with Alzheimer's disease. She was ...
via Bing News